Duchenne Muscular Dystrophy

New England CEPAC
July 25, 2019 10am-4pm ET

Boston, MA

The New England CEPAC will convene to deliberate and vote on evidence presented in ICER's report on treatments for Duchenne muscular dystrophy.

Key Dates

Associated Materials

12/13/2018 – 01/08/2019
Open Input Period

01/11/2019

01/11/2019 – 02/01/2019
Public Comments

01/11/2019
Stakeholder List

02/11/2019
Revised Scoping Document

03/19/2019
Research Protocol

04/09/2019
Model Analysis Plan

05/22/2019
Draft Evidence Report

05/22/2019
Draft Evidence Report

05/22/2019 – 06/18/2019
Public Comments

07/11/2019
Evidence Report

07/11/2019
Revised Voting Questions

07/11/2019
Response to Comments

07/25/2019
Meeting Agenda

07/25/2019
Evidence Presentation

08/15/2019
Final Evidence Report and Meeting Summary

08/15/2019
Report-at-a-Glance